These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 37878314)

  • 21. Impact of proactive high-throughput functional assay data on BRCA1 variant interpretation in 3684 patients with breast or ovarian cancer.
    Kim HK; Lee EJ; Lee YJ; Kim J; Kim Y; Kim K; Lee SW; Chang S; Lee YJ; Lee JW; Lee W; Chun S; Son BH; Jung KH; Kim YM; Min WK; Ahn SH
    J Hum Genet; 2020 Mar; 65(3):209-220. PubMed ID: 31907386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups.
    Chung W; Jiang SF; Paksarian D; Nikolaidis A; Castellanos FX; Merikangas KR; Milham MP
    JAMA Netw Open; 2019 Nov; 2(11):e1914344. PubMed ID: 31675080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variant classification changes over time in the clinical molecular diagnostic laboratory setting.
    Hahn E; Mighton C; Fisher Y; Wong A; Di Gioacchino V; Watkins N; Mayers J; Bombard Y; Charames GS; Lerner-Ellis J
    J Med Genet; 2024 Jul; 61(8):788-793. PubMed ID: 38806232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk.
    Caswell-Jin JL; Gupta T; Hall E; Petrovchich IM; Mills MA; Kingham KE; Koff R; Chun NM; Levonian P; Lebensohn AP; Ford JM; Kurian AW
    Genet Med; 2018 Feb; 20(2):234-239. PubMed ID: 28749474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and Reclassification of Genetic Variants in South African Populations with Breast Cancer.
    Osler TS; Brandenburg JT; Schoeman M; Chen WC; Urban MF; Mathew CG
    Genes Chromosomes Cancer; 2024 Sep; 63(9):e23275. PubMed ID: 39324485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines.
    So MK; Jeong TD; Lim W; Moon BI; Paik NS; Kim SC; Huh J
    Breast Cancer; 2019 Jul; 26(4):510-519. PubMed ID: 30725392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary Cancer.
    Karam R; Conner B; LaDuca H; McGoldrick K; Krempely K; Richardson ME; Zimmermann H; Gutierrez S; Reineke P; Hoang L; Allen K; Yussuf A; Farber-Katz S; Rana HQ; Culver S; Lee J; Nashed S; Toppmeyer D; Collins D; Haynes G; Pesaran T; Dolinsky JS; Tippin Davis B; Elliott A; Chao E
    JAMA Netw Open; 2019 Oct; 2(10):e1913900. PubMed ID: 31642931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epilepsy panels in clinical practice: Yield, variants of uncertain significance, and treatment implications.
    Brock DC; Abbott M; Reed L; Kammeyer R; Gibbons M; Angione K; Bernard TJ; Gaskell A; Demarest S
    Epilepsy Res; 2023 Jul; 193():107167. PubMed ID: 37230012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ancestry-specific hereditary cancer panel yields: Moving toward more personalized risk assessment.
    Roberts ME; Susswein LR; Janice Cheng W; Carter NJ; Carter AC; Klein RT; Hruska KS; Marshall ML
    J Genet Couns; 2020 Aug; 29(4):598-606. PubMed ID: 32227564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance.
    Richardson ME; Hu C; Lee KY; LaDuca H; Fulk K; Durda KM; Deckman AM; Goldgar DE; Monteiro ANA; Gnanaolivu R; Hart SN; Polley EC; Chao E; Pesaran T; Couch FJ
    Am J Hum Genet; 2021 Mar; 108(3):458-468. PubMed ID: 33609447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Racial/Ethnic Disparities in the Performance of Prediction Models for Death by Suicide After Mental Health Visits.
    Coley RY; Johnson E; Simon GE; Cruz M; Shortreed SM
    JAMA Psychiatry; 2021 Jul; 78(7):726-734. PubMed ID: 33909019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cosmic Whirl: Navigating the Comet Trail in DNA: H2AX Phosphorylation and the Enigma of Uncertain Significance Variants.
    Ustun Yilmaz S; Agaoglu NB; Manto K; Muftuoglu M; Özbek U
    Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort.
    Mariathasan S; Andrews KA; Thompson E; Challis BG; Wilcox S; Pierce H; Hale J; Spiden S; Fuller G; Simpson HL; Fish B; Jani P; Seetho I; Armstrong R; Izatt L; Joshi M; Velusamy A; Park SM; Casey RT
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):409-418. PubMed ID: 32430905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reclassification of Genetic Testing Results: A Case Report Demonstrating the Need for Structured Re-Evaluation of Genetic Findings.
    Schott C; Colaiacovo S; Baker C; Weir MA; Connaughton DM
    Can J Kidney Health Dis; 2024; 11():20543581241242562. PubMed ID: 38623282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center.
    Chapman-Davis E; Zhou ZN; Fields JC; Frey MK; Jordan B; Sapra KJ; Chatterjee-Paer S; Carlson AD; Holcomb KM
    J Gen Intern Med; 2021 Jan; 36(1):35-42. PubMed ID: 32720237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Architecture of Dilated Cardiomyopathy in Individuals of African and European Ancestry.
    Jordan E; Kinnamon DD; Haas GJ; Hofmeyer M; Kransdorf E; Ewald GA; Morris AA; Owens A; Lowes B; Stoller D; Tang WHW; Garg S; Trachtenberg BH; Shah P; Pamboukian SV; Sweitzer NK; Wheeler MT; Wilcox JE; Katz S; Pan S; Jimenez J; Fishbein DP; Smart F; Wang J; Gottlieb SS; Judge DP; Moore CK; Mead JO; Hurst N; Cao J; Huggins GS; Cowan J; Ni H; Rehm HL; Jarvik GP; Vatta M; Burke W; Hershberger RE;
    JAMA; 2023 Aug; 330(5):432-441. PubMed ID: 37526719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the Diagnostic Yield of Combined Cardiomyopathy and Arrhythmia Genetic Testing.
    Dellefave-Castillo LM; Cirino AL; Callis TE; Esplin ED; Garcia J; Hatchell KE; Johnson B; Morales A; Regalado E; Rojahn S; Vatta M; Nussbaum RL; McNally EM
    JAMA Cardiol; 2022 Sep; 7(9):966-974. PubMed ID: 35947370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Racial and ethnic disparities in diagnostic efficacy of comprehensive genetic testing for sensorineural hearing loss.
    Florentine MM; Rouse SL; Stephans J; Conrad D; Czechowicz J; Matthews IR; Meyer AK; Nadaraja GS; Parikh R; Virbalas J; Weinstein JE; Chan DK
    Hum Genet; 2022 Apr; 141(3-4):495-504. PubMed ID: 34515852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A likelihood-based approach to assessing frequency of pathogenicity among variants of unknown significance in susceptibility genes.
    Yang Y; Hong C; Liang JW; Gruber S; Parmigiani G; Idos G; Braun D
    Stat Med; 2021 Feb; 40(3):593-606. PubMed ID: 33120437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective genotype-phenotype analysis in a 305 patient cohort referred for testing of a targeted epilepsy panel.
    Hesse AN; Bevilacqua J; Shankar K; Reddi HV
    Epilepsy Res; 2018 Aug; 144():53-61. PubMed ID: 29778030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.